Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Merck (MRK) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Tickers MRK
Exposures Financial Product Safety
$750 Million Projected Market; NRx Pharmaceuticals, Inc files Citizens Petition to FDA Seeking Removal of Benzethonium Chloride from Ketamine Products
Via PRLog
Exposures Product Safety
Why Is Replimune Stock Trading Lower On Monday?
Via Benzinga
Tickers BMY REPL
Exposures Product Safety
Ibogaine by David Dardashti Warns of Kratom’s ‘Gateway’ Dangers, Citing Alarming Trend in Patient Addiction Cases
Via AB Newswire
Exposures Product Safety
AbbVie Raises 2025 Outlook After Q2 Beat
Via The Motley Fool
Tickers ABBV
Exposures Product Safety
BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Petitions FDA to Ban Benzethonium Chloride from Ketamine Products
Via Investor Brand Network
Topics Intellectual Property
Tickers NRXP
Exposures Intellectual Property Product Safety
Levi & Korsinsky Reminds Capricor Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 15, 2025 - CAPR
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Levi & Korsinsky Reminds Replimune Group, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 22, 2025 - REPL
Via NewMediaWire
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Contact Levi & Korsinsky by August 11, 2025 Deadline to Join Class Action Against Rocket Pharmaceuticals, Inc. (RCKT)
Via NewMediaWire
Topics Fraud Lawsuit
Tickers RCKT
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Reminds Replimune Group, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 22, 2025 - REPL
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Reminds Capricor Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 15, 2025 - CAPR
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Contact Levi &amp; Korsinsky by August 11, 2025 Deadline to Join Class Action Against Rocket Pharmaceuticals, Inc. (RCKT)
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers RCKT
Exposures Financial Legal Product Safety
Late-Stage Pipeline Wins Boost Investor Confidence in High-Growth Therapeutic Areas
Via FinancialNewsMedia
Topics Government
Tickers BMY INSM MRK PFE
Exposures Political Product Safety
5 Facts About Sexual Dysfunction in Women and How to Get Help
Via StatePoint Media
Exposures Product Safety
From Apothecary to Global Powerhouse: The Enduring Legacy of Pfizer
Via MarketMinute
Topics Economy
Tickers PFE
Exposures COVID-19 Interest Rates Product Safety
Levi & Korsinsky Notifies Capricor Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - CAPR
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
August 11, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against RCKT
Via NewMediaWire
Topics Fraud Lawsuit
Tickers RCKT
Exposures Financial Legal Product Safety
Levi & Korsinsky Reminds Replimune Group, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 22, 2025 - REPL
Via NewMediaWire
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Notifies Capricor Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - CAPR
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Reminds Replimune Group, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 22, 2025 - REPL
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
August 11, 2025 Deadline: Contact Levi &amp; Korsinsky to Join Class Action Suit Against RCKT
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers RCKT
Exposures Financial Legal Product Safety
Exponent (EXPO) Q2 Revenue Rises 1%
Via The Motley Fool
Topics Artificial Intelligence Product Recall
Tickers EXPO
Exposures Artificial Intelligence Legal Product Safety
Alnylam's Amvuttra Makes Powerful Entrance, Eyes First-Line Dominance
Via Benzinga
Tickers ALNY
Exposures Product Safety
What Are the Must-Have Certifications for Medical Heat Exchangers?
Via AB Newswire
Topics Product Recall
Exposures Legal Product Safety
Novo Nordisk's Alhemo Wins FDA Nod, Expanding Subcutaneous Option For Hemophilia Patients
Via Benzinga
Tickers NVO SNY
Exposures Product Safety
LENZ Therapeutics' Eye Drop Scores First FDA Approval For Age-Related Blurred Vision Condition Impacting 128 Million People
Via Benzinga
Tickers LENZ
Exposures Product Safety
iRhythm (IRTC) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings Law Enforcement World Trade
Tickers IRTC
Exposures Financial Legal Product Safety
Regeneron's Pipeline Hit By Catalent Delays, But Dupixent Shines
Via Benzinga
Tickers NVO REGN SNY
Exposures Product Safety
2 Top Stocks I Wouldn't Hesitate to Invest $1,000 in Right Now
Via The Motley Fool
Tickers LULU VRTX
Exposures Product Safety
AtrendLtd Launches "Investing in Medical Innovation" Initiative to Accelerate Healthcare Transformation
Via 24-7 Press Release
Tickers PFE
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.